ACR-2024-MET medical data_error ai_generated true

AI instructs a diabetic patient to continue metformin during and after iodinated contrast administration without renal function check

ID: medical/contrast-hold-metformin

Also available as: JSON · Markdown · 中文
82%Fix Rate
86%Confidence
1Evidence
2024-05-20First Seen

Root Cause

Iodinated contrast can cause contrast-induced nephropathy (CIN), reducing renal clearance of metformin and precipitating lactic acidosis, a rare but fatal complication. Guidelines (ACR, ESUR) require checking eGFR before contrast; if eGFR <30 mL/min/1.73m², metformin must be held 48h before and after contrast; if eGFR 30-60, hold day of contrast and for 48h after.

generic

中文

碘造影剂可导致造影剂肾病（CIN），降低二甲双胍的肾脏清除率，诱发乳酸性酸中毒——一种罕见但致命的并发症。指南（ACR、ESUR）要求造影前检查eGFR；若eGFR<30 mL/min/1.73m²，需在造影前后各停用二甲双胍48小时；若eGFR 30-60，造影当日及之后48小时停用。

Official Documentation

https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf

Workarounds

  1. 90% success Check eGFR before contrast. If eGFR >60 mL/min/1.73m²: continue metformin normally. If eGFR 30-60: hold metformin on day of contrast and for 48h after, then recheck eGFR. If eGFR <30: hold metformin 48h before and 48h after contrast, recheck eGFR before resuming. 
    Check eGFR before contrast. If eGFR >60 mL/min/1.73m²: continue metformin normally. If eGFR 30-60: hold metformin on day of contrast and for 48h after, then recheck eGFR. If eGFR <30: hold metformin 48h before and 48h after contrast, recheck eGFR before resuming.
  2. 80% success For emergency contrast where pre-procedure eGFR is unavailable, hold metformin immediately, administer contrast, and check eGFR post-procedure. Resume metformin only if eGFR >30 and no evidence of CIN (creatinine rise <0.3 mg/dL). 
    For emergency contrast where pre-procedure eGFR is unavailable, hold metformin immediately, administer contrast, and check eGFR post-procedure. Resume metformin only if eGFR >30 and no evidence of CIN (creatinine rise <0.3 mg/dL).

中文步骤

  1. Check eGFR before contrast. If eGFR >60 mL/min/1.73m²: continue metformin normally. If eGFR 30-60: hold metformin on day of contrast and for 48h after, then recheck eGFR. If eGFR <30: hold metformin 48h before and 48h after contrast, recheck eGFR before resuming.
  2. For emergency contrast where pre-procedure eGFR is unavailable, hold metformin immediately, administer contrast, and check eGFR post-procedure. Resume metformin only if eGFR >30 and no evidence of CIN (creatinine rise <0.3 mg/dL).

Dead Ends

Common approaches that don't work:

  1. Assuming all diabetic patients on metformin need to stop before contrast regardless of renal function 50% fail

    Overly cautious; patients with normal renal function (eGFR >60) can continue metformin safely. The decision depends on eGFR.

  2. Telling patient to resume metformin immediately after contrast without checking post-procedure renal function 75% fail

    If CIN develops, the reduced eGFR may still put the patient at risk; guidelines recommend waiting 48h and confirming renal function stable before resuming.

  3. Using BUN or creatinine alone without calculating eGFR 65% fail

    Creatinine alone is misleading in elderly or low muscle mass patients; eGFR (CKD-EPI equation) is the standard for metformin dosing decisions.